medigraphic.com
Colegio de Medicina Interna de México.

2008, Number 5

<< Back Next >>

Med Int Mex 2008; 24 (5)

Obesity, arterial hypertension, and diabetes mellitus: start or end points of the same problem?

Rodríguez WF, Gabriela Sáez TG

Language: Spanish
References: 22
Page: 342-345
PDF size: 158.97 Kb.


ABSTRACT

Systemic arterial hypertension, diabetes and obesity are worldwide health problems, they can be found alone or as part of the metabolic syndrome, which can be accompanied by dysfunction in lipid metabolism and insulin resistance, and eventually by other diseases. They, by themselves, increase the risk of systemic vascular disease, and together the morbidity and mortality risks in severe vascular cerebral and cardiac diseases. Today we have enough information to detect these problems during childhood and adolescence so we can adopt real preventive measures in order to improve life quality, life time and decrease vascular disease in our patients.


REFERENCES

  1. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894:i-xii, 1-253.

  2. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998;21(9):1414-31.

  3. Lara EA, Rosas PM, Pastelín HG, Aguilar SC y col. Hipercolesterolemia e hipertensión arterial en México. Consolidación urbana actual con obesidad, diabetes y tabaquismo. Arch Cardiol Mex 2004;74(3)231-45.

  4. Rivera JA, Barquera S, Campirano F, Campos I, et al. Epidemiological and nutritional transition in México: rapid increased of non-communicable chronic diseases and obesity. Public Health Nutr 2002;5(1A):113-22.

  5. Violante OR, Porres A. Diabesidad: un enfoque epidemiológico y preventivo. Med Int Mex 2005;21(5):386-92.

  6. Carey VJ, Walters EE, Colditz GA, Solomon CG, et al. Body fat distribution and risk of non-insulin-dependent diabetes mellitus in women. The Nurses´ Health Study. Am J Epidemiol 1997;145(7):614-9.

  7. Rosas MP, Lara EA, Pastelín HG, Velázquez MO y col. Re-encuesta nacional de hipertensión arterial (RENAHTA): Consolidación mexicana de los factores de riesgo cardiovascular. Cohorte Nacional de Seguimiento. Arch Cardiol Mex 2005;75(1):96-111.

  8. Bloomgarden ZT. Definitions of the insulin resistance syndrome: the 1st World Congress on the Insulin Resistance Syndrome. Diabetes Care 2004;27(3):824-30.

  9. Consenso Mexicano sobre el Tratamiento Integral del Síndrome Metabólico. Rev Mex Cardiol 2002;13(1):4-30.

  10. Weis R, Dziura J, Burgest TS, Tamborlane WV, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004;350(23):2362-74.

  11. Lakka TA, Lakka HM, Salonen R, Kaplan GA, et al. Abdominal obesity is associated with accelerated progression of carotid atherosclerosis in men. Atherosclerosis 2001;154(2):497- 504.

  12. Reaven GM. The insulin resistance syndrome: definition and dietary approaches to treatment. Annu Rev Nutr 2005;25:391- 406.

  13. Goodpaster BH, Krishnaswami S, Resnik H, Kelley DE, et al. Association between regional adipose tissue distribution and both type 2 diabetes and impaired glucose tolerance in elderly men and women. Diabetes Care 2003;26(2):372-9.

  14. Alessi MC, Lijnen HR, Bastelica D, Juhan-Vague I. Adipose tissue and aterothrombosis. Pathophysiol Haemos Thromb 2003-2004;33(5-6):290-7.

  15. Lebovitz HE, Banerji MA. Treatment of insulin resistance in diabetes mellitus. Eur J Pharmacol 2004;490(1-3):135-46.

  16. Alvarado R. Microalbuminemia. Gac Méd Méx 2006;142(Supl 1).

  17. Casas JP, Bautista LE, Smeeth L, Shama P, Hingorani AD. Homocisteína e ictus: evidencia de una relación casual basada en una asignación aleatoria mendeliana. The Lancent 2006;2:61-69 (edición español).

  18. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. The Lancet 2005;365(9468):1415-28.

  19. Moller DE, Kaufman KD. Metabolic syndrome: a clinical and molecular perspective. Annu Rev Med 2005;56:45-62.

  20. Mora S, Yanek LR, Moy TF, Fallin MD, et al. Interaction of body mass index and Framingham risk score in predicting incident coronary disease in families. Circulation 2005;111(15):1871-6.

  21. Lakka HM, Lakka TA, Tuomilehto J, Siverius J, Salonen JT. Hyperinsulinemia and the risk of cardiovascular death and acute coronary and cerebrovascular events in men: the Kuopio Ischaemic Heart Disease Risk Factor Study. Arch Intern Med 2000;160(8):1160-8.

  22. Hjemdahl P. Stress and metabolic syndrome: an interesting but enigmatic association. Circulation 2002;106(21):2634-6.




2020     |     www.medigraphic.com